Haoma Medica Completes First-in-Human Trial for NaQuinate, a N...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
LONDON, Nov. 26, 2020 /PRNewswire-AsiaNet/ -- Haoma Medica announced today the completion of a first-in-human trial for NaQuinate, a naphthoquinone carboxylic acid, which is being developed as a novel orally administered therapeutic for osteoporosis.The first-in-human trial initiated la...
Authors: LATEST ASIANET NEWS RELEASES